As the UAE strengthens its efforts to combat diabetes, healthcare professionals emphasize the importance of early detection, lifestyle changes, and mental health support. With World Diabetes Day highlighting the theme of 'Early Action on Diabetes,' experts stress that timely dia…
A recent study published in Obesity Science & Practice explored strategies to help individuals maintain weight loss after discontinuing GLP-1 receptor agonists, medications often…
Recent research suggests that Ozempic-like medications, which include semaglutide, may influence alcohol cravings and consumption patterns. While some studies indicate a reduction…
A recent study published in the journal Obesity investigates the effects of time-restricted eating on weight loss and eating behaviors in adults with obesity and prediabetes. The…
Emerging research highlights the potential of microdosing GLP-1 receptor agonists, such as semaglutide, during perimenopause to manage metabolic health. This approach may help add…
A recent study from Johns Hopkins Medicine finds that time-restricted eating (TRE) may lead to modest weight loss in adults with obesity and prediabetes. The research, published i…
This article explores the influence of GLP-1 receptor agonists on self-control and weight management, challenging traditional views that attribute weight issues solely to individu…
Research into GLP-1 medications, such as Ozempic and Wegovy, indicates they may play a role in reducing cancer risk by improving metabolic health, but the evidence remains mixed a…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
Recent research indicates that semaglutide, a drug used for weight loss, may also extend lifespan and improve health measures in elderly mice. While the findings are intriguing, t…
Recent research indicates that semaglutide, a medication commonly used for type 2 diabetes and weight management, may also reduce asthma attacks by nearly 40% and COPD flare-ups b…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…